The Docmode Health Technologies IPO has begun on 25-January-2024. It will close on 31-January-2024. The Total IPO Size is 6.71 Crores. The company set its IPO price is 79 Rs Per Share. Basically, There are two basic categories in Docmode Health Technologies IPO Subscription 1) others 2) Retail Individual Investors (RIIs)
Docmode Health Technologies is established in 2017.
Docmode Health Technologies is provides integrated learning solutions for healthcare professionals and learners worldwide through online and offline learning models.
The company’s offline learning modules include conferences and workshops, while the online modules include courses developed by the company’s content development team or by medical institutions and medical associations (medical professional organizations) and experts/opinion leaders.
The company also provides a platform for interprofessional, cross-sector learning through panel discussions and courses, and users can utilize its performance assessment tools to improve their clinical acumen in daily medical practice.
The company offers a total of 87 certificate programs and is affiliated with over 35 medical associations and universities around the world.
Check :- Upcoming SME IPO 2024
Docmode Health Technologies IPO Promotor Holding
Paulson Paul Thazhathedath and Hans Albert Lewis are the promoters of the company.
Docmode Health Technologies IPO Date, Details & Price Band
IPO Opening Dates | 25-January-2024 |
IPO Closing Dates | 30-January-2024 |
Price Band | 79 Rs |
Fresh Issue | 6.71 Crore |
Total IPO size | 6.71 Crore |
Minimum bid (lot size) | 1600 Shares |
Face Value | 10 INR Per Share |
Listing On | NSE SME |
Docmode Health Technologies IPO Market Lot
The Docmode Health Technologies IPO minimum market lot is 1600 shares With 126,400 ₹ Amount per application.
Lot | No of Shares | Amount | |
Minimum | 1 | 1600 | 126,400 Rs |
Maximum | 1 | 1600 | 126,400 Rs |
S-HNI (Min) | 2 | 3200 | 252,800 Rs |
Restated Financial Record of the three year (Amt. in Lakhs)
Total Assets | Total Revenue | Profit After Tax | |
31-Mar-21 | 567.26 | 710.46 | 55.33 |
31-Mar-22 | 1,008.36 | 1,243.76 | 92.20 |
31-Mar-23 | 1,700.88 | 3,297.42 | 194.82 |
Docmode Health Technologies IPO GMP Grey Market Premium
Docmode Health Technologies IPO GMP Grey market premium has been started today. Check Latest Docmode Health Technologies IPO GMP Grey market premium, Kostak Rates and Subject to Sauda Price here.
Docmode Health Technologies IPO Prospectus
DRHP | Download |
RHP | Download |
Docmode Health Technologies IPO Reviews
AngelOne – Update Soon
Choice Broking – Update Soon
Prabhudas Lilladher – Update Soon
Docmode Health Technologies IPO Form Download
Docmode Health Technologies IPO is available on NSE Website as well as on our Portal. Please click here Docmode Health Technologies IPO form Download.
Docmode Health Technologies IPO Allotment Date & Details
Allotment Date | 31-January-2024 |
Initiation of refunds | 01-February-2024 |
Transfer of shares to Demat accounts | 01-February-2024 |
Listing Date | 02-February-2024 |
Check Allotment Status | Click here </td> |
Registrar of Docmode Health Technologies IPO
BIGSHARE SERVICES PRIVATE LIMITED
Office No. S6 – 2, 6th Floor,
Pinnacle Business Park, Next to Ahura Centre,
Mahakali Cave Road, Andheri – [East], Mumbai – 400093, Maharashtra, India.
Tel No.: +91 22 6263 8200
Fax No.: +91 22 6263 8299
Email: [email protected]
Website: www.bigshareonline.com
Contact Person: Mr. Aniket Chindarkar
SEBI Registration No.: INR000001385
Docmode Health Technologies Contact Details
Docmode Health Technologies Limited
201, Kalpataru Plaza,
Rambaug Off Chincholi Bunder Road,
Malad Mumbai – 400064
Phone: +919920923338
Email: [email protected]
Website: https://docmode.org/
Docmode Health Technologies IPO Lead Managers
FEDEX SECURITIES PRIVATE LIMITED
B 7, 3rd Floor, Jay Chambers, Dayaldas Road, Vile Parle – [East],
Mumbai – 400 057, Maharashtra, India
Tel No.: +91 81049 85249
E-mail: [email protected]
Website: www.fedsec.in
Contact Person: Saipan Sanghvi
SEBI Registration Number: INM000010163
Investor Grievance E-Mail: [email protected]